Shuqiang Li

China Medical University

Papers

1

Total Citations

89

H-Index

1

About

Dr. Shuqiang Li is a leading figure in the field of hepatopancreatobiliary surgery, with a primary research focus on the safety and efficacy of minimally invasive surgical techniques, particularly robotic-assisted pancreatic surgery. His most influential work, a 2018 systematic review and meta-analysis comparing robot-assisted versus open pancreaticoduodenectomy and distal pancreatectomy, has garnered 89 citations, establishing a critical evidence base for the adoption of robotic approaches. This landmark study systematically evaluated perioperative outcomes, demonstrating that robotic surgery can achieve comparable safety profiles to open procedures while potentially reducing hospital stays and blood loss. Dr. Li’s contributions have been instrumental in guiding clinical decision-making and advancing the paradigm shift toward less invasive pancreatic resections. His rigorous methodology and focus on patient-centered outcomes have made him a respected voice in surgical oncology, helping to define best practices for complex pancreatic surgeries. Through his work, Dr. Li continues to shape the future of surgical care, providing surgeons with the data needed to optimize treatment strategies for patients with pancreatic diseases.

Research Focus

Key Achievements

1
H-Index
1
Papers
89
Total Citations
89
Avg Citations/Paper
🏆 Most Cited Paper
Safety and efficacy for robot-assisted versus open pancreaticoduodenectomy and distal pancreatectomy: A systematic review and meta-analysis
89 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: China Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago